Market Closed -
Nasdaq
21:00:00 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
29.61
USD
|
+1.09%
|
|
-4.73%
|
-12.11%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,633
|
2,921
|
5,116
|
5,473
|
5,968
|
5,147
|
-
|
-
|
Enterprise Value (EV)
1 |
3,852
|
3,946
|
6,062
|
6,243
|
6,686
|
5,806
|
5,497
|
5,136
|
P/E ratio
|
-30.4
x
|
-391
x
|
36.9
x
|
36.3
x
|
22.8
x
|
25.5
x
|
22.3
x
|
19.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.14
x
|
0.96
x
|
1.49
x
|
1.39
x
|
1.39
x
|
1.09
x
|
1
x
|
0.92
x
|
EV / Revenue
|
1.67
x
|
1.3
x
|
1.76
x
|
1.58
x
|
1.55
x
|
1.22
x
|
1.06
x
|
0.92
x
|
EV / EBITDA
|
29.5
x
|
17.8
x
|
20.9
x
|
18.2
x
|
15.7
x
|
13.1
x
|
11.2
x
|
9.4
x
|
EV / FCF
|
345
x
|
39.3
x
|
33.1
x
|
26.9
x
|
20.3
x
|
22
x
|
20
x
|
16
x
|
FCF Yield
|
0.29%
|
2.55%
|
3.02%
|
3.72%
|
4.93%
|
4.55%
|
5.01%
|
6.23%
|
Price to Book
|
-
|
2.79
x
|
4.35
x
|
3.95
x
|
-
|
3.45
x
|
3.18
x
|
2.91
x
|
Nbr of stocks (in thousands)
|
176,462
|
186,759
|
179,875
|
181,901
|
177,131
|
173,816
|
-
|
-
|
Reference price
2 |
14.92
|
15.64
|
28.44
|
30.09
|
33.69
|
29.61
|
29.61
|
29.61
|
Announcement Date
|
05/03/20
|
11/03/21
|
23/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,310
|
3,033
|
3,439
|
3,945
|
4,302
|
4,741
|
5,163
|
5,591
|
EBITDA
1 |
130.8
|
221.7
|
289.8
|
342.9
|
425.2
|
442.9
|
492.1
|
546.4
|
EBIT
1 |
68.71
|
110.8
|
190.8
|
240.2
|
314.6
|
324.8
|
368.2
|
411.3
|
Operating Margin
|
2.97%
|
3.65%
|
5.55%
|
6.09%
|
7.31%
|
6.85%
|
7.13%
|
7.36%
|
Earnings before Tax (EBT)
1 |
-78.19
|
-5.243
|
116.5
|
205.8
|
358.7
|
274.7
|
320.2
|
371.6
|
Net income
1 |
-75.92
|
-8.076
|
139.9
|
150.6
|
267.1
|
204.2
|
232.9
|
266.5
|
Net margin
|
-3.29%
|
-0.27%
|
4.07%
|
3.82%
|
6.21%
|
4.31%
|
4.51%
|
4.77%
|
EPS
2 |
-0.4900
|
-0.0400
|
0.7700
|
0.8300
|
1.480
|
1.162
|
1.325
|
1.496
|
Free Cash Flow
1 |
11.18
|
100.5
|
182.9
|
232.2
|
329.4
|
264.2
|
275.2
|
320
|
FCF margin
|
0.48%
|
3.31%
|
5.32%
|
5.89%
|
7.66%
|
5.57%
|
5.33%
|
5.72%
|
FCF Conversion (EBITDA)
|
8.55%
|
45.34%
|
63.12%
|
67.72%
|
77.48%
|
59.65%
|
55.93%
|
58.56%
|
FCF Conversion (Net income)
|
-
|
-
|
130.76%
|
154.22%
|
123.34%
|
129.38%
|
118.16%
|
120.05%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/03/20
|
11/03/21
|
23/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
927.2
|
915.8
|
980.8
|
1,021
|
1,027
|
1,016
|
1,069
|
1,093
|
1,124
|
1,146
|
1,172
|
1,203
|
1,237
|
1,250
|
1,283
|
EBITDA
1 |
86.75
|
77.78
|
85.18
|
85.62
|
94.27
|
93.77
|
110
|
109.8
|
111.6
|
98.29
|
107.5
|
116
|
122.2
|
112.1
|
125
|
EBIT
1 |
60.77
|
52.24
|
59.08
|
60.72
|
68.19
|
66.62
|
82.37
|
81.05
|
84.56
|
69.03
|
78.64
|
86.15
|
91.01
|
82.91
|
93.54
|
Operating Margin
|
6.55%
|
5.7%
|
6.02%
|
5.95%
|
6.64%
|
6.56%
|
7.7%
|
7.42%
|
7.52%
|
6.02%
|
6.71%
|
7.16%
|
7.36%
|
6.63%
|
7.29%
|
Earnings before Tax (EBT)
1 |
46.97
|
41.27
|
47.64
|
52.08
|
64.78
|
54.23
|
155.5
|
70.08
|
78.92
|
56.96
|
66.41
|
72.67
|
78.5
|
70.79
|
80.54
|
Net income
1 |
75.47
|
30.28
|
33.93
|
38.82
|
47.53
|
39.21
|
114.4
|
56.3
|
57.18
|
44.79
|
48.24
|
53.46
|
57.35
|
51.08
|
58.73
|
Net margin
|
8.14%
|
3.31%
|
3.46%
|
3.8%
|
4.63%
|
3.86%
|
10.7%
|
5.15%
|
5.09%
|
3.91%
|
4.12%
|
4.44%
|
4.63%
|
4.09%
|
4.58%
|
EPS
2 |
0.4100
|
0.1700
|
0.1900
|
0.2100
|
0.2600
|
0.2100
|
0.6300
|
0.3100
|
0.3200
|
0.2600
|
0.2750
|
0.3050
|
0.3300
|
0.2933
|
0.3400
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/02/22
|
28/04/22
|
27/07/22
|
27/10/22
|
23/02/23
|
03/05/23
|
27/07/23
|
25/10/23
|
22/02/24
|
23/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,219
|
1,025
|
946
|
770
|
719
|
659
|
350
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
10.8
|
Leverage (Debt/EBITDA)
|
9.326
x
|
4.624
x
|
3.266
x
|
2.246
x
|
1.691
x
|
1.489
x
|
0.7122
x
|
-
|
Free Cash Flow
1 |
11.2
|
101
|
183
|
232
|
329
|
264
|
275
|
320
|
ROE (net income / shareholders' equity)
|
-10.1%
|
-0.84%
|
12.8%
|
11.8%
|
19%
|
14.7%
|
15.2%
|
15.7%
|
ROA (Net income/ Total Assets)
|
-
|
-0.31%
|
5.05%
|
5.13%
|
8.44%
|
7.01%
|
7.02%
|
7.44%
|
Assets
1 |
-
|
2,622
|
2,768
|
2,937
|
3,165
|
2,913
|
3,319
|
3,581
|
Book Value Per Share
2 |
-
|
5.610
|
6.540
|
7.620
|
-
|
8.580
|
9.300
|
10.20
|
Cash Flow per Share
2 |
-
|
0.7000
|
1.150
|
1.470
|
2.060
|
1.750
|
1.950
|
2.250
|
Capex
1 |
28.3
|
26.9
|
25.6
|
35.4
|
41.9
|
42.3
|
44.3
|
44.7
|
Capex / Sales
|
1.22%
|
0.89%
|
0.75%
|
0.9%
|
0.97%
|
0.89%
|
0.86%
|
0.8%
|
Announcement Date
|
05/03/20
|
11/03/21
|
23/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
29.61
USD Average target price
39.45
USD Spread / Average Target +33.23% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.11% | 5.15B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|